Key result
In octogenarians with cardiac diseases, a systolic pulmonary artery pressure >35 mmHg was associated with increased 5-year all-cause mortality (HR 1.7; 95% CI 1.1-2.6; p=0.013).
Why the study?
Does elevated systolic pulmonary artery pressure (sPAP >35 mmHg) increase 5-year all-cause mortality in octogenarians with CHF or ACS?
Cohort (n=302)
Yes
Does elevated systolic pulmonary artery pressure (sPAP >35 mmHg) increase 5-year all-cause mortality in octogenarians with CHF or ACS?
In octogenarians with CHF or ACS, a systolic pulmonary artery pressure >35 mmHg is associated with a significantly increased risk of 5-year all-cause mortality.
OBJECTIVE: Elevated systolic pulmonary artery pressure (sPAP) is common among elderly patients with cardiac and pulmonary diseases. The lowest level of sPAP associated with increased mortality rate in octogenarians with cardiac diseases is however not sufficiently studied. Therefore, the present study aimed to identify the lowest level of sPAP associated with increased 5-year all-cause mortality in this patient group. DESIGN: Of 538 octogenarians presented at the three Sahlgrenska University Hospitals (Sahlgrenska, Östra and Mölndal) with either congestive heart failure (CHF) or acute coronary syndrome (ACS), only 302 patients who had undergone echocardiography with data on sPAP were included in the present study. In order to identify the lowest level of sPAP associated with increased mortality rate, Cox proportional-hazard regression multivariable models were built for sPAP levels as low as 30 mmHg and upward with 5 mmHg intervals. RESULTS: sPAP >35 mmHg was identified as the lowest level associated with increased 5-year all-cause mortality (HR = 1.7, 95% of CI = 1.1-2.6 and p = .013). Every increase of 5 mmHg in sPAP was associated with a 10% increased relative risk for all-cause mortality. CONCLUSIONS: In octogenarians with cardiac diseases the lowest level of sPAP associated with increased all-cause mortality was >35 mmHg and the mortality rate increased with increasing sPAP.
No takes yet. Share an insight, caveat, or question.
Barywani et al. (2018) conducted a cohort in Congestive heart failure or acute coronary syndrome (n=302). Systolic pulmonary artery pressure (sPAP) >35 mmHg vs. sPAP ≤35 mmHg was evaluated on 5-year all-cause mortality (HR 1.7, 95% CI 1.1-2.6, p=0.013). In octogenarians with cardiac diseases, a systolic pulmonary artery pressure >35 mmHg was associated with increased 5-year all-cause mortality (HR 1.7; 95% CI 1.1-2.6; p=0.013).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: